These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37759556)

  • 1. Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders.
    Martínez-Iglesias O; Naidoo V; Carrera I; Carril JC; Cacabelos N; Cacabelos R
    Biology (Basel); 2023 Aug; 12(9):. PubMed ID: 37759556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of anxiety and depression in Alzheimer's disease.
    Cacabelos R; Carril JC; Corzo L; Pego R; Cacabelos N; Alcaraz M; Muñiz A; Martínez-Iglesias O; Naidoo V
    Pharmacogenomics; 2023 Jan; 24(1):27-57. PubMed ID: 36628952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease.
    Cacabelos R; Carril JC; Corzo L; Fernández-Novoa L; Pego R; Cacabelos N; Cacabelos P; Alcaraz M; Tellado I; Naidoo V
    Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33920985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetic screening for polymorphisms in drug-metabolizing enzymes and drug transporters in a Dutch population.
    Bosch TM; Doodeman VD; Smits PH; Meijerman I; Schellens JH; Beijnen JH
    Mol Diagn Ther; 2006; 10(3):175-85. PubMed ID: 16771603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of CYP4F2, CYP2C19, and CYP1A2 polymorphisms on acenocoumarol pharmacogenomic algorithm accuracy improvement in the Greek population: need for sub-phenotype analysis.
    Ragia G; Karantza IM; Kelli-Kota E; Kolovou V; Kolovou G; Konstantinides S; Maltezos E; Tavridou A; Tziakas D; Maitland-van der Zee AH; Manolopoulos VG
    Drug Metab Pers Ther; 2017 Dec; 32(4):183-190. PubMed ID: 29252193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding role of pharmacogenomics in the management of cardiovascular disorders.
    Yip VL; Pirmohamed M
    Am J Cardiovasc Drugs; 2013 Jun; 13(3):151-62. PubMed ID: 23579966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexketoprofen Pharmacokinetics is not Significantly Altered by Genetic Polymorphism.
    Mejía-Abril G; Zubiaur P; Navares-Gómez M; Villapalos-García G; Román M; Ochoa D; Abad-Santos F
    Front Pharmacol; 2021; 12():660639. PubMed ID: 33995083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms.
    Hirota T; Takane H; Higuchi S; Ieiri I
    Curr Drug Metab; 2008 Jan; 9(1):34-8. PubMed ID: 18220569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of tamoxifen therapy in Asian populations: from genetic polymorphism to clinical outcomes.
    Wang T; Zhou Y; Cao G
    Eur J Clin Pharmacol; 2021 Aug; 77(8):1095-1111. PubMed ID: 33515076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development.
    Cacabelos R; Naidoo V; Martínez-Iglesias O; Corzo L; Cacabelos N; Pego R; Carril JC
    Methods Mol Biol; 2022; 2547():275-387. PubMed ID: 36068470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of polymorphisms in transporter and metabolizing enzyme genes on olanzapine pharmacokinetics and safety in healthy volunteers.
    Zubiaur P; Soria-Chacartegui P; Koller D; Navares-Gómez M; Ochoa D; Almenara S; Saiz-Rodríguez M; Mejía-Abril G; Villapalos-García G; Román M; Martín-Vílchez S; Abad-Santos F
    Biomed Pharmacother; 2021 Jan; 133():111087. PubMed ID: 33378980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol pharmacogenetics: clinical and functional evidence for the role of SLCO1B1/OATP1B1 in flavopiridol disposition.
    Ni W; Ji J; Dai Z; Papp A; Johnson AJ; Ahn S; Farley KL; Lin TS; Dalton JT; Li X; Jarjoura D; Byrd JC; Sadee W; Grever MR; Phelps MA
    PLoS One; 2010 Nov; 5(11):e13792. PubMed ID: 21072184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention.
    Saiz-Rodríguez M; Belmonte C; Caniego JL; Koller D; Zubiaur P; Bárcena E; Romero-Palacián D; Eugene AR; Ochoa D; Abad-Santos F
    Clin Ther; 2019 Jun; 41(6):1199-1212.e2. PubMed ID: 31128980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics and therapeutic prospects in dementia.
    Cacabelos R
    Eur Arch Psychiatry Clin Neurosci; 2008 Mar; 258 Suppl 1():28-47. PubMed ID: 18344047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacogenetics and pharmacogenomics: why is this relevant to the clinical geneticist?
    Nebert DW
    Clin Genet; 1999 Oct; 56(4):247-58. PubMed ID: 10636440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting
    Kalla P; Namerow LB; Walker SA; Ruaño G; Malik S
    Pharmacogenomics; 2023 Feb; 24(3):131-139. PubMed ID: 36727491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of Vascular Risk Factors in Alzheimer's Disease.
    Cacabelos R; Meyyazhagan A; Carril JC; Cacabelos P; Teijido Ó
    J Pers Med; 2018 Jan; 8(1):. PubMed ID: 29301387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients.
    Zhang D; Hao J; Hou R; Yu Y; Hu B; Wei L
    J Clin Pharm Ther; 2020 Jun; 45(3):561-569. PubMed ID: 32364660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring pharmacogenetics in special groups: geriatrics.
    Seripa D; Panza F; Daragjati J; Paroni G; Pilotto A
    Expert Opin Drug Metab Toxicol; 2015 Jul; 11(7):1073-88. PubMed ID: 25990744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.